Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo

Cancer Research

Volumn 62, Issue 19, 2002, Pages 5571-5579

  Bendre, Manali S ^a   Gaddy Kurten, Dana ^a   Mon Foote, Thetsu ^a   Akel, Nisreen S ^a   Skinner, Robert A ^a   Nicholas, Richard W ^a   Suva, Larry J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; INTERLEUKIN 8; PARATHYROID HORMONE RELATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CONTROLLED STUDY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE NEOPLASMS; BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE HORMONES; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036792257     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Martin, T. J., and Moseley, J. M. Mechanisms in the skeletal complications of breast cancer. Endocr. Relat. Cancer, 7: 271-284, 2000.
2. Eisman, J. A., Suva, L. J., and Martin, T. J. Significance of 1. 25-dihydroxyvitamin D3 receptor in primary breast cancers. Cancer Res., 46: 5406-5408, 1986.
3. Harris, J., Lippman, M., Veronesi, U., and Willett, W. Breast cancer. N. Eng. J. Med., 327: 319-328. 1992.
4. Chu, K., Tarone, R., Kessler, L., Ries, L., Hankey, B., Miller, B., and Edwards, B. Recent trends in U. S. breast cancer incidence, survival, and mortality rates. J. Natl. Cancer Inst. (Bethesda), 88: 1571-1579, 1996.
5. Weiss, L. Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin. Exp. Metastasis, 10: 191-199, 1992.
6. Yoneda, T., Williams, P., Hiraga, T., Niewolna, M., and Nishimura, R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental breast cancer cells and a brain-seeking clone in vivo and in vitro. J. Bone Miner. Res., 16: 1486-1495, 2001.
7. Fidler, I. Modulation of the organ microenvironment for treatment of cancer metastasis. J. Natl. Cancer Inst. (Bethesda), 87: 1588-1592, 1995.
8. Boyce, B., Yoneda, T., and Guise, T. Factors regulating the growth of metastatic cancer in bone. Endocr. Relat. Cancer, 6: 333-347, 1999.
9. Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J. A., Henderson. M. A., Bennett, R. C., and Martin, T. J. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res., 51: 3059-3061, 1991.
10. Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massague, J., Mundy, G. R., and Guise, T. A. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Investig. 103: 197-206, 1999.
11. Carron, J. A., Fraser, W. D., and Gallagher, J. A. PTHrP and the PTH/PTHrP receptor are co-expressed in human breast and colon turnouts. Br. J. Cancer, 76: 1095-1098, 1997.
12. Zhang, Q. X., Borg, A., Wolf, D. M., Oesterreich, S., and Fuqua, S. A. An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer. Cancer Res., 57: 1244-1249, 1997.
13. De Larco, J., Wuertz, B., Rosner, K., Erickson, S., Gamache, D., and Furcht, L. A potential role for interleukin 8 in the metastatic phenotype of breast carcinoma cells. Am. J. Pathol., 158: 639-646, 2001.
14. Yoshimura. T., Matsushima, K., Tanaka, S., Robinson, E., Appella, E., Oppenheim, J., and Leonard, E. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA, 84: 9233-9237, 1987.
15. Sozzani, S., Locati, M., Allavena, P., Van Damme, J., and Mantovani, A. Chemokines: a superfamily of chemotactic cytokines. Int. J. Clin. Lab. Res., 26: 69-82, 1996.
16. Leek, R., Landers, R., Fox, S., Ng, F., Harris, A., and Lewis, C. Association of tumor necrosis factor a and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br. J. Cancer, 77: 2246-2251, 1998.
17. Cailleau, R., Young, R., Olive, M., and Reeves, W. J. Beast tumor cells from pleural effusions. J. Natl. Can. Inst. (Bethesda), 53: 661-674, 1974.
18. Skinner, R., Hickmon, S., Lumpkin, C., Jr. A., Aronson, J. A., and Nicholas, R. Decalcified bone: twenty years of successful specimen management. J. Histotechnol., 20: 267-277, 1997.
19. Suva, L. J., Seedor, J. G., Endo, N., Quartuccio, H. A., Thompson, D. D., Bab, I., and Rodan, G. A. Pattern of gene expression following rat tibial marrow ablation. J. Bone Miner. Res., 8: 379-388, 1993.
20. Thompson, E. W., Brunner, N., Torri, J., Johnson, M. D., Boulay, V., Wright, A., Lippman, M. E., Steeg, P. S., and Clarke, R. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin. Exp. Metastasis, 11: 15-26, 1993.
21. Rajah, T., and Pento, J. Influence of antiestrogens on the invasiveness and laminin attachment of breast cancer cells. Cancer Investig., 17: 10-18, 1999.
22. Eliopoulos, A. G., Kerr, D. J., Herod, J., Hodgkins, L., Krajewski, S., Reed, J. C., and Young, L. S. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and bcl-2. Oncogene, 11: 1217-1228, 1995.
23. Adams, A. E., Rosenblatt, M., and Suva, L. J. Identification of a novel parathyroid hormone-responsive gene in human osteoblastic cells. Bone (NY), 24: 305-313, 1999.
24. Prichett, W. P., Patton, A. J., Field, J. A., Brun, K. A., Emery, J. G., Tan, K. B., Rieman, D. J., McClung, H. A., Nadeau, D. P., Mooney, J. L., Suva, L. J., Gowen, M., and Nuttall, M. E. Identification and cloning of a human urea transporter HUT11, which is down-regulated during adipogenesis of explant cultures of human bone. J. Cell. Biochem., 76: 639-650, 2000.
25. Zhan, F., Hardin, J., Kordsmeier, B., Bumm, K., Zheng, M., Tian, E., Sanderson, R., Yang, Y., Wilson, C., Zangari, M., Anaissie, E., Morris, C., Muwalla, F., van Rhee, F., Fassas, A., Crowley, J., Tricot. G., Barlogie, B., and Shaughnessy, J., Jr. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood, 99: 1745-1757, 2002.
26. Khanna, C., Khan, J., Nguyen, P., Prehn, J., Caylor, J., Yeung, C., Trepel, J., Meltzer, P., and Helman, L. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res., 61: 3750-3759, 2001.
27. Mukaida, N., Mahe, Y., and Matsushima, K. Cooperative interaction of nuclear factor ΚB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J. Biol. Chem., 265: 21128-21133, 1990.
28. Suva, L. J., Winslow, G. A., Wettenhall, R. E., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., Rodda, C. P., Kemp, B. E., Rodriguez, H., Chen, E. Y., et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science (Wash. DC), 237: 893-896, 1987.
29. Pandian, M., Morgan, C., Carlton, E., and Segre, G. Modified immunoradiometric assay for parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia. Clin. Chem., 38: 282-288, 1992.
30. Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., and Mundy, G. R. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J. Clin. Investig., 98: 1544-1549, 1996.
31. Fidler, I. Critical factors in the biology of human cancer metastasis. Cancer Res., 50: 6130-6138, 1990.
32. Jensen, F., Gwatkin, R., and Bigers, J. A simple method which allows simultaneous isolation of specific types of cells. Exp. Cell Res., 34: 440-447, 1964.
33. Arguello, F., Baggs, R., and Frantz, C. A murine model of experimental metastasis to bone. Cancer Res., 48: 6876-6881, 1988.
34. Pines, M., Adams, A., Stueckle, S., Bessalle, R., Rashti-Behar, V., Chorev, M., Rosenblatt, R., and Suva, L. Generation and characterization of human kidney cell lines stably expressing recombinant human PTH/PTHrP receptor: lack of interaction with a C-terminal human PTH peptide. Endocrinology, 135: 1713-1716, 1994.
35. Thomas, R., Guise, T., Yin, J., Elliot, J., Horwood, N., Martin, T., and Gillespie, M. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology, 140: 4451-4458, 1999.
36. Southby, J., Kissin, M. W., Danks, J. A., Hayman, J. A., Moseley, J. M., Henderson, M. A., Bennett, R. C., and Martin, T. J. Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res., 50: 7710-7716, 1990.
37. Danks, J. A., Ebeling, P. R., Hayman, J., Chou, S. T., Moseley, J. M., Dunlop, J., Kemp, B. E., and Martin, T. J. Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin. J. Bone Miner. Res., 4: 273-278, 1989.
38. Ten Dijke, P., Goumans, M. J., Itoh, F., and Itoh, S. Regulation of cell proliferation by Smad proteins. J. Cell. Physiol., 191: 1-16. 2002.
39. Kim, S., Uehara, H., Karashima, T., Mccarty, M., Shih, N., and Fidler, I. Expression of interleukin 8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia, 3: 33-42, 2001.
40. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet, i: 571-573, 1889.
41. Walther, H. Krebsmetastasen. Basel. Switzerland: Bens Schwabe Verlag, 1948.
42. Cifuentes, N., and Pickren, J. Metastases from carcinoma of mammary gland: an autopsy study. J. Surg. Oncol., 11: 193-205, 1979.
43. Coleman, R., and Rubens, R. The clinical course of bone metastases from breast cancer. Br. J. Cancer, 55: 61-66, 1987.
44. Peyruchaud, O., Winding, B., Pecheur, I., Serre, C. M., Delmas, P., and Clezardin, P. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions. J. Bone Miner. Res., 16: 2027-2034, 2001.
45. Khan, J., Bittner, M. L., Saal, L. H., Teichmann, U., Azorsa, D. O., Gooden, G. C., Pavan, W. J., Trent, J. M., and Meltzer, P. S. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. USA, 96: 13264-13269, 1999.
46. Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., Sampas, N., Dougherty, E., Wang, E., Marincola, F., Gooden, C., Lueders, J., Glatfelter, A., Pollock, P., Carpten, J., Gillanders, E., Leja, D., Dietrich, K., Beaudry, C., Berens, M., Alberts, D., and Sondak, V. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (Lond.), 406: 536-540, 2000.
47. Amundson, S. A., Do, K. T., Shahab, S., Bittner, M., Meltzer, P., Trent, J., and Fornace, A. J., Jr. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat. Res., 154: 342-346, 2000.
48. Henderson, M., Danks, J., Moseley, J., Slavin, J., Harris, T., McKinlay, M., Hopper, J., and Martin, T. Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases. J. Natl. Cancer Inst. (Bethesda), 93: 234-237, 2001.
49. Mundy, G. R., and Yoneda, T. Facilitation and suppression of bone metastasis. Clin. Orthop. Relat. Res., 312: 34-44, 1995.
50. Rossi, D., and Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol., 18: 217-242, 2000.
51. Brandolini, L., Bertini, R., Bizzarri, C., Sergi, R., Caselli, G., Zhou, D., Locati, M., and Sozzani, S. IL-1 β primes IL-8-activated human neutrophils for elastase release, phospholipase D activity, and calcium flux. J. Leukocyte Biol., 59: 427-434, 1996.
52. Rothe, L., Collin-Osdoby, P., Chen, Y., Sunyer, T., Chaudhary, L., Tsay, A., Goldring, S., Avioli, L., and Osdoby, P. Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology, 139: 4353-4363, 1998.
53. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., and Strieter, R. M. CXC chemokines in angiogenesis. J. Leukocyte Biol., 68: 1-8, 2000.
54. Chaudhary, L. R., and Avioli, L. V. Dexamethasone regulates IL-1 β and TNF-α-induced interleukin-8 production in human bone marrow stromal and osteoblast-like cells. Calcif. Tissue Int., 55: 16-20, 1994.
55. Fuller, K., Owens, J. M., and Chambers, T. J. Macrophage inflammatory protein-1 α and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J. Immunol., 154: 6065-6072, 1995.
56. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., and Martin, T. J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev., 20: 345-357, 1999.
57. Motoyoshi, K. Biological activities and clinical application of M-CSF. Int. J. Hematol., 67: 109-122, 1998.